Pepsinogen I, pepsinogen II, gastrin-17, and Helicobacter pylori serological biomarkers in the diagnosis of precursor lesions of gastric cancer [PDF]
Introduction Atrophic gastritis and intestinal metaplasia are precursor lesions of gastric cancer. The aim of this study was to determine the usefulness of the biomarkers pepsinogen I(PgI), pepsinogen II (PgII), gastrin-17, and H.
Josefina Yoaly Sánchez-López +2 more
doaj +3 more sources
Low Pepsinogen I Level Predicts Multiple Gastric Epithelial Neoplasias for Endoscopic Resection [PDF]
Background/AimsSynchronous/metachronous gastric epithelial neoplasias (GENs) in the remaining lesion can develop at sites other than the site of endoscopic resection.
Park SY +7 more
doaj +3 more sources
Longitudinal Changes in the Serum Pepsinogen I/II Ratio With Progression of Gastric Atrophy [PDF]
Serum pepsinogen (PG) I/II ratio decreased with progression of gastric mucosal atrophy and showed consistent intra‐individual changes over time. In a large cohort with repeated endoscopic evaluations, longitudinal declines in the PG I/II ratio paralleled worsening atrophic stages.
Soie Chung +5 more
wiley +2 more sources
Gastritis is an inflammatory process in the gastric mucosa and submucosa caused by Helicobacter pylori (H. pylori). The infection modulates immune components, such as interleukin (IL) 17, high sensitivity C-reactive protein (hsCRP) and pepsinogen.
Jeanne Winarta +5 more
doaj +2 more sources
The impact of washed microbiota transplantation on serum gastric function markers: pepsinogen I, pepsinogen II, and Gastrin-17 [PDF]
Background and aimsConventional treatment methods for gastric diseases have problems such as drug resistance and recurrence. This study aims to explore whether a new treatment method—Washed Microbiota Transplantation (WMT)—can improve gastric mucosal ...
Youlin Song +16 more
doaj +2 more sources
Exploring the High‐Risk Factors of Gastric “Inflammatory Cancer Transformation” Based on Inflammatory Immune Response: Construction of RHPI Complicated With CAG Risk Prediction Model [PDF]
ABSTRACT Objective To investigate risk factors for refractory Helicobacter pylori infection (RHPI) complicated by chronic atrophic gastritis (CAG) and to develop a risk prediction model for early identification of high‐risk patients. Methods A retrospective cohort study enrolled 367 RHPI patients from January 2015 to December 2024.
Tian‐tong Jiang +10 more
wiley +2 more sources
Differential impacts of Helicobacter pylori antibody typing on gastric secretory function: a cross-sectional study based on serum biomarkers [PDF]
Objective Although gastric secretory dysfunction is common in H.pylori-associated gastropathy, the precise mechanisms underlying these functional alterations across different H.pylori antibody subtypes remain incompletely elucidated. This cross-sectional
Hongyuan Xu +7 more
doaj +2 more sources
Efficacy and safety of oral Chinese patent medicine combined with quadruple therapy for chronic atrophic gastritis: a systematic review and network meta-analysis [PDF]
BackgroundChronic atrophic gastritis (CAG) is an important precancerous lesion of gastric cancer, with Helicobacter pylori (H. pylori) infection being a major etiological factor. Although quadruple therapy is the first-line treatment for H.
Dan Han, Yang Yu, Bo-yi Wang, Zhan-ze Ma
doaj +2 more sources
Serum gastrin 17, pepsinogen I and pepsinogen II in atrophic gastritis patients living in North-East of Iran [PDF]
Background : Gastric carcinoma is the second most common cause of cancer-related death in Iran. It is well-known that atrophic gastritis is a major risk factor for gastric cancer, which leads to variations in the serum levels of gastrin 17 (G-17 ...
Mosalreza Hosseini +6 more
doaj +2 more sources
Regional variations in serum pepsinogen levels and their influencing factors: a multi-center cross-sectional study [PDF]
Serum pepsinogen (PG) levels are recognized biomarkers influenced by various factors, including lifestyle, Helicobacter pylori (H. pylori) infection status, and the presence of gastric mucosal lesions.
Huang Jiaojiao, Yu Jiaying, Tong Yuling
doaj +2 more sources

